Resonant Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Buy |
4,771
+354
| +8% | +$32.4K | 0.03% | 259 |
|
|
2025
Q1 | $501K | Sell |
4,417
-83
| -2% | -$9.41K | 0.03% | 210 |
|
|
2024
Q4 | $476K | Buy |
4,500
+207
| +5% | +$21.9K | 0.03% | 212 |
|
|
2024
Q3 | $464K | Sell |
4,293
-174
| -4% | -$18.8K | 0.03% | 219 |
|
|
2024
Q2 | $486K | Buy |
4,467
+407
| +10% | +$44.3K | 0.04% | 208 |
|
|
2024
Q1 | $537K | Buy |
4,060
+24
| +0.6% | +$3.17K | 0.05% | 195 |
|
|
2023
Q4 | $492K | Buy |
4,036
+426
| +12% | +$51.9K | 0.05% | 183 |
|
|
2023
Q3 | $406K | Buy |
3,610
+236
| +7% | +$26.5K | 0.04% | 183 |
|
|
2023
Q2 | $492K | Buy |
3,374
+16
| +0.5% | +$2.33K | 0.05% | 169 |
|
|
2023
Q1 | $435K | Buy |
3,358
+58
| +2% | +$7.51K | 0.05% | 175 |
|
|
2022
Q4 | $422K | Buy |
3,300
+228
| +7% | +$29.1K | 0.05% | 182 |
|
|
2022
Q3 | $322K | Buy |
3,072
+149
| +5% | +$15.6K | 0.05% | 184 |
|
|
2022
Q2 | $308K | Sell |
2,923
-26
| -0.9% | -$2.74K | 0.05% | 196 |
|
|
2022
Q1 | $378K | Buy |
2,949
+258
| +10% | +$33.1K | 0.06% | 164 |
|
|
2021
Q4 | $332K | Buy |
2,691
+232
| +9% | +$28.6K | 0.05% | 164 |
|
|
2021
Q3 | $350K | Buy |
2,459
+769
| +46% | +$109K | 0.06% | 153 |
|
|
2021
Q2 | $264K | Buy |
1,690
+49
| +3% | +$7.65K | 0.05% | 159 |
|
|
2021
Q1 | $255K | Buy |
1,641
+32
| +2% | +$4.97K | 0.05% | 161 |
|
|
2020
Q4 | $241K | Sell |
1,609
-85
| -5% | -$12.7K | 0.06% | 162 |
|
|
2020
Q3 | $224K | Sell |
1,694
-470
| -22% | -$62.1K | 0.06% | 151 |
|
|
2020
Q2 | $251K | Buy |
+2,164
| New | +$251K | 0.07% | 157 |
|